Posts

Psychedelic Business Spotlight – April 29
Business, Stock ReportsThis week in psychedelic business news: Field Trip Health splits in two, Tryp Therapeutics commences study, and Optimi Health celebrates new facility.

Psychedelic Business Spotlight – December 24
Business, Stock ReportsThis week in psychedelic business news: FDA green lights a new psilocybin study; MindMed commences LSD treatment for ADHD; Sage Institute shuffles leadership.

FDA Green Lights Tryp Therapeutics’ Psilocybin Study on Binge Eating Disorder
ResearchThe pharmaceutical company developing psilocybin-based compounds for diseases with unmet medical needs estimates a $2.9 billion market potential for such a treatment.

Psychedelic Business Spotlight: November 5
Business, Stock ReportsThis week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.

Psychedelic Business Spotlight: August 13, 2021
Business, Stock ReportsThis week in psychedelic business news: Psychedelics in development to treat eye diseases and stroke; companies gear up for new clinical trials investigating psychedelics for general anxiety, chronic pain,...

Psychedelic Business Spotlight: July 9, 2021
Business, Stock ReportsThis week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.